Clinical Trials on Cardiovascular Health in Australia

Total 3051 results

MyoKardia, Inc.

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Oral Doses of MYK-461 in Healthy Volunteers

Healthy

Australia
Flinders University
medac GmbH; University of South Australia

Recruiting

Methotrexate, Blood Pressure and Arterial Function in Rheumatoid Arthritis

Rheumatoid Arthritis | Endothelial Dysfunction | Cardiovascular Risk Factor | Stiffness, Aortic

Australia
ZYUS Life Sciences Inc.
Novotech (Australia) Pty Limited; ZYUS Life Sciences Australia Pty Ltd

Completed

Trichomylin® Safety, Tolerability & Pharmacokinetics in Healthy Adults and First in Human Osteoarthritis Pain Evaluation (HOPE)

Healthy | Osteoarthritis

Australia
Peter MacCallum Cancer Centre, Australia
Melbourne Health

Completed

NMP in Relapsed / Refractory Myeloma

Multiple Myeloma

Australia
Medical University of Vienna

Completed

Resistance to Antithrombotic Therapy (Vienna REACT)

Atherosclerosis | Angioplasty

Austria
Claudia Herbst

Completed

Copeptin- Relevance as a Perioperative Marker in Pediatric Cardiac Surgery

Congenital Heart Disease

Austria
Royal Prince Alfred Hospital, Sydney, Australia

Completed

Cardiotoxicity of Adjuvant Trastuzumab (CATS)

Heart Failure | Breast Neoplasms

Australia
Turgut Ardika PTY LTD

Recruiting

Comparative PK, Safety, Tolerability, Immunogenicity, and PD Profile Study of TUR03 and Soliris in Healthy Participants

Healthy

Australia
Circadian Therapeutics Ltd
Neuroscience Trials Australia

Completed

First in Human Study of CT-1500 in Healthy Participants

Healthy

Australia
Arrowhead Pharmaceuticals

Completed

A Study of ARC-520 at Varying Infusion Rates in Healthy Adult Volunteers

Healthy

Australia
Medical University Innsbruck
Heart and Diabetes Center North Rhine-Westphalia; Austrian Science Fund (FWF)

Recruiting

Liver Disease, Myocardial Fibrosis and Collaterals in the Adult Fontan Patient a Metabolomics and Proteomics Approach

Liver Diseases | Myocardial Fibrosis | Heart Defects, Congenital | Patient Participation | Collateral Circulation, Any Site

Austria
Liverpool Heart and Chest Hospital NHS Foundation...
Papworth Hospital NHS Foundation Trust

Completed

The SoundScar Study The SOUNDSCAR Study (SoundScar)

Ventricular Tachycardia | Ischemic Cardiomyopathy

Australia, United Kingdom
Monash Medical Centre
Middlemore Hospital, New Zealand; Prince of Wales Hospital, Sydney; Auckland... and other collaborators

Unknown

Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis (TWISTER)

Venous Thrombosis | Pulmonary Embolism

Australia, New Zealand
Medical University of Vienna

Completed

The Effect of Clopidogrel and Ticagrelor With and Without Acetylsalicylic Acid (ASA) on Hemostatic System Activation at the Site of Plug Formation in Vivo in Man

Acute Coronary Syndrome

Austria
Annexon, Inc.
Nucleus Network Ltd

Completed

A Single and Multiple Ascending Dose Study of ANX009 in Normal Healthy Volunteers (NHV)

Safety and Tolerability in Healthy Volunteers

Australia
University of Sydney
National Health and Medical Research Council, Australia

Completed

Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema

Diabetic Retinopathy | Macular Edema

Australia
C. R. Bard

Active, not recruiting

Study of BD Sirolimus Drug Coated Catheter for Treatment of Femoropopliteal Arteries (PREVISION)

Peripheral Arterial Disease | Peripheral Artery Disease | Stenosis Artery

Australia, New Zealand, Singapore
Medical University of Graz

Suspended

Definition of Hemodynamic Thresholds in Out-of-Hospital Cardiac Arrest (HETOCA)

Cardiac Arrest

Austria
Kepler University Hospital
Medtronic

Completed

Impact of Pacing Mode and Diastolic Function on Cardiac Output (PADIAC)

Diastolic Function | Cardiac Output | AV Block | Pacemaker Stimulation Mode | Stroke Volume

Austria
Unilever R&D
Commonwealth Scientific and Industrial Research Organisation, Australia

Completed

The Effect of Plant Sterols on the Blood Lipid Profile of Subjects With and at High Risk of Type 2 Diabetes Mellitus

Vascular Diseases | Diabetes Mellitus | Hypercholesterolemia

Australia
Melbourne Health
National Health and Medical Research Council, Australia

Terminated

Impact of Diabetes and Glucose Control During Rehabilitation After Stroke

Hyperglycemia | Diabetes | Cerebrovascular Accident

Australia
Bayside Health

Unknown

Atorvastatin in Myeloma

Myeloma

Australia
Merck KGaA, Darmstadt, Germany

Completed

First-in-Human Trial of Single Ascending Dose, Multiple Ascending Dose and Malaria Challenge Model in Healthy Participants

Healthy

Australia
Peter MacCallum Cancer Centre, Australia
Celgene Corporation

Unknown

A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression

Multiple Myeloma

Australia
GlaxoSmithKline

Withdrawn

A Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple Myeloma

Cancer

Australia
Peter MacCallum Cancer Centre, Australia
Celgene Corporation; Janssen-Cilag Ltd.

Unknown

A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma

Multiple Myeloma

Australia
Aeovian Pharmaceuticals, Inc.

Recruiting

Assessment of the Safety, Tolerability and Pharmacokinetics of AV078 in Healthy Volunteers

Healthy Participants

Australia
InSilico Medicine Hong Kong Limited

Recruiting

Study Evaluating ISM5411 Administered Orally to Healthy Volunteers

Healthy Subjects

Australia
Alebund Pty Ltd

Completed

A Pharmacodynamic Effect Study of AP301 in Healthy Volunteers

Healthy Subjects

Australia
Sonnet BioTherapeutics

Completed

Study of SON-1010 (IL12-FHAB) in Healthy Adults

Healthy Adult

Australia
Alebund Pty Ltd

Completed

A Safety, Tolerability, and Pharmacokinetics Study of AP303 in Healthy Subjects

Healthy Subjects

Australia
Supernus Pharmaceuticals, Inc.

Completed

Evaluating the Safety and Relative Bioavailability of Three SPN-817 Treatments (A, B and C) in Healthy Adult Subjects

Healthy Volunteer

Australia
Arthrosi Therapeutics

Completed

The Study is Designed to Evaluate Single Ascending Doses of AR882 in Healthy Adult Males

Healthy Volunteers

Australia
Alvotech Swiss AG

Completed

Comparative Safety, Tolerability, Pharmacokinetic Study of AVT02 (100MG/ML) and Humira (100MG/ML) in Healthy Volunteers (ALVOPAD)

Healthy Volunteers

Australia
Hutchison Medipharma Limited

Completed

A Study of HMPL-689 in Healthy Volunteers

Healthy Volunteers

Australia
Medicines for Malaria Venture
Syneos Health; Nucleus Network Ltd

Completed

Study To Investigate The Relative Bioavailability of OZ439 Formulations In Healthy Volunteers

Healthy Volunteers

Australia
afreeze GmbH

Completed

Cryoablation of Atrial Fibrillation Using a Novel Cryoablation System

Atrial Fibrillation

Austria
Medical University of Graz

Recruiting

Prospective Database for Prediction of Atrial Fibrillation in Pacemaker and ICD Patients (SAFE-ME)

Atrial Fibrillation | ICD | Pacemaker Ddd

Austria
ModernaTX, Inc.

Recruiting

Study to Investigate Safety and Tolerability of mRNA-0184 Administered at 2 Different Infusion Durations in Healthy Participants

Healthy Participants

Australia
Diceros Therapeutics
Diceros Therapeutics Australia Pty Ltd

Not yet recruiting

Phase 1, SAD/MAD of Verasone™ Administered by Sinonasal Irrigation in Healthy Participants

Healthy Volunteers

Australia
TeneoFour Inc.
Novotech (Australia) Pty Limited

Completed

A Single and Multiple Dosing Study Targeting Biparatopic Antibody CD38 in Healthy Volunteers

Healthy Volunteer

Australia
Arcus Biosciences, Inc.

Completed

A Study to Investigate the Safety of AB680 in Healthy Volunteers

Healthy Volunteers

Australia
Arcus Biosciences, Inc.

Completed

A Study to Investigate the Pharmacokinetic Profile of Oral AB680 in Healthy Volunteers

Healthy Volunteers

Australia
GenFleet Therapeutics (Australia) Pty Ltd.

Completed

A Study of GFH312 in Healthy Subjects

Healthy | Toxicity

Australia
ModernaTX, Inc.

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of mRNA-6231 in Healthy Adults

Healthy Volunteers

Australia
Baliopharm Pty Ltd

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Atrosimab (ATM001) in Healthy Volunteers

Healthy Volunteers

Australia
CymaBay Therapeutics, Inc.

Completed

Study Investigating the Safety, Tolerability, and PK, PD, of CB-0406

Healthy Volunteers

Australia
Alpine Immune Sciences, Inc.
Clinical Network Services (CNS) Pty Ltd

Completed

Adult Healthy Volunteers Study to Evaluate ALPN-101 Safety

Healthy Volunteers

Australia
Noxopharm Limited

Withdrawn

A Study of Safety and Tolerability of NOX66 in Healthy Volunteers

Healthy Volunteers

Australia
Prana Biotechnology Limited

Completed

Phase 1 Study to Determine the Effects of PBT2 on the Pharmacokinetic Profile of Caffeine

Healthy Volunteers

Australia

Clinical Trials on Cardiovascular Health in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations